[SLN] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Mar-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 18.55%
YoY- 8.74%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 4,765 3,371 3,643 5,722 3,414 3,156 2,701 45.85%
PBT -15,050 -9,326 -13,420 -9,572 -11,227 -12,052 -12,708 11.90%
Tax -1,287 -2,223 -1,481 -1,888 -1,793 -2,123 -1,080 12.36%
NP -13,763 -7,103 -11,939 -7,684 -9,434 -9,929 -11,628 11.85%
Tax Rate - - - - - - - -
Total Cost 18,528 10,474 15,582 13,406 12,848 13,085 14,329 18.63%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -288.84 -210.71 -327.72 -134.29 -276.33 -314.61 -430.51 -23.30%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.43 -0.22 -0.40 -0.26 -0.32 -0.33 -0.39 6.70%
EPS Diluted -0.43 -0.22 -0.40 -0.26 -0.32 -0.33 -0.39 6.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.